Yes. Mutation is also driven partly by infection rates, so a virus that mutates slowly and infects 1 billion people is going to produce dangerous new strains more rapidly than a virus that mutates quickly and infects 100 people.
> Is there a reason beyond cash incentive?
Yes. Flu vaccines targeted at emerging strains are much, much more effective.
"This year's" flu vaccine is never 100% effective on any strain (which is true of all vaccines), but there's a huge difference between a vaccine that's 80% effective for the majority of flu infections vs. a vaccine that's 20% effective.